Pfizer “Approvable” Streak Continues With Second letter For Anidulafungin

The antifungal agent’s second approvable letter is for an esophageal candidiasis indication.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet